Clinical Trials Logo

Carcinosarcomas Uterine clinical trials

View clinical trials related to Carcinosarcomas Uterine.

Filter by:
  • None
  • Page 1

NCT ID: NCT03509207 Terminated - Leiomyosarcoma Clinical Trials

Vorinostat (SAHA) in Uterine Sarcoma

Start date: December 14, 2017
Phase: Phase 2
Study type: Interventional

Uterine sarcomas are rare tumors with a poor prognosis. The main purpose of this phase II proof-of-principle- pilot study is to test the efficacy of the hydroxamic acid-based Histone deacetylase inhibitor (HDACI) Vorinostat (SAHA) as monotherapy in patients with HDAC-positive, progressive, metastatic uterine sarcomas and mixed epithelial and mesenchymal tumors after prior anti-proliferative therapy.

NCT ID: NCT02993705 Completed - Clinical trials for Carcinosarcoma, Ovarian

Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)

MITO 26
Start date: February 22, 2017
Phase: Phase 2
Study type: Interventional

Multicenter phase II study on trabectedin in patients advanced uterine and ovarian carcinosarcoma. Patients will receive trabectedin until disease progression or unacceptable toxicity. Disease response evaluation will be assessed every 9 weeks.